Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jun 2026 for BridgeBio Pharma, Inc..
Filing timeline
BuySaleFred Hassan
Insider track record
Disclosed buys
3
Disclosed sells
0
Signal history
Closed purchases
Market purchases
3
Positive at T+90
0%
Median T+90
-26.2%
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -36.6%Entry US$1.72 · Close at T+365 US$1.09
- -51.6%Entry US$16.29 · Close at T+365 US$7.88
- -58.2%Entry US$30.22 · Close at T+365 US$12.64
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fred Hassan: trading record in brief
Fred Hassan, a Director, has 36 filings from May 5, 2016 to June 24, 2026, spread across Precigen, Inc. (20), Amgen Inc (5), Time Warner Inc. (4), BridgeBio Pharma, Inc. (3) and Cocrystal Pharma, Inc. (2).
The market trades are 3 purchases and no sale: EUR 914,862 at Precigen on August 14, 2023, EUR 241,622 at BridgeBio Pharma on December 29, 2021 and EUR 189,045 at Precigen on December 1, 2016, EUR 1,345,529 in total, median EUR 241,622. The rest of the record is 20 grants, 11 option exercises and 2 other lines.
The yearly volume stays low and smooth, from 2 filings in 2021 to 5 in 2023. Four filings fall in the last twelve months, with no purchase. Filings are published a median of 3 days after the trade. Randal J. Kirk has 2 trades within 30 days of trades by Fred Hassan, in the same direction; Andrew Lo, Brent L. Saunders, Douglas A. Dachille and Hannah Valantine have one each.
Companies and markets linked to Fred Hassan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations36 total
3,990 sharesCommon StockSEC:0001470831-26-000629:0
71,839 sharesCommon StockSEC:0000950103-26-003833:0
17,948 shares@ US$3.514.6% of flowCommon StockSEC:0000950103-26-003687:0
359,713 shares@ US$1.39100.0% of flowCommon StockSEC:0001493152-25-020221:0
6,589 shares0Common StockSEC:0000950170-25-089647:0
87,412 sharesCommon StockSEC:0000950103-25-003518:1
36,206 shares@ US$1.744.9% of flowCommon StockSEC:0000950103-25-003518:0
8,067 sharesCommon StockSEC:0001493152-24-040899:0
44,055 shares@ US$1.434.8% of flowCommon StockSEC:0000950103-24-003955:0
106,837 sharesCommon StockSEC:0000950103-24-003746:0
570,345 shares@ US$1.7577.0% of flowCommon StockSEC:0000950103-23-012143:0
Canonical exit: 12 Nov 2023 (T+90)
2,123 sharesCommon StockSEC:0000899243-23-015758:0
2,123 shares0Common StockSEC:0001209191-23-031175:0
48,290 shares@ US$1.174.5% of flowCommon StockSEC:0000950103-23-004007:0
61,576 sharesCommon StockSEC:0000950103-23-003029:0
16,212 sharesCommon StockSEC:0000950103-22-005404:0
27,832 shares@ US$2.034.2% of flowCommon StockSEC:0000950103-22-003221:0
19,300 shares@ US$14.1653100.0% of flowCommon StockSEC:0000899243-22-000176:0
Canonical exit: 29 Mar 2022 (T+90)
7,328 shares@ US$7.713.0% of flowCommon StockSEC:0001123292-21-000565:0
62,189 sharesCommon StockSEC:0001123292-21-000487:0
846 shares0Common StockSEC:0001127602-20-015851:0
28,109 shares@ US$2.014.1% of flowCommon StockSEC:0001123292-20-000568:0
24,703 sharesCommon StockSEC:0001123292-20-000537:0
1,127 shares0Common StockSEC:0001127602-19-017638:0
7,911 sharesCommon StockSEC:0001123292-19-000572:0
25 of 36 declarations
